X-55009124-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000032.5(ALAS2):c.*56A>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.011 in 1,172,771 control chromosomes in the GnomAD database, including 898 homozygotes. There are 3,456 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.057 ( 457 hom., 1739 hem., cov: 22)
Exomes 𝑓: 0.0062 ( 441 hom. 1717 hem. )
Consequence
ALAS2
NM_000032.5 3_prime_UTR
NM_000032.5 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.247
Genes affected
ALAS2 (HGNC:397): (5'-aminolevulinate synthase 2) The product of this gene specifies an erythroid-specific mitochondrially located enzyme. The encoded protein catalyzes the first step in the heme biosynthetic pathway. Defects in this gene cause X-linked pyridoxine-responsive sideroblastic anemia. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant X-55009124-T-G is Benign according to our data. Variant chrX-55009124-T-G is described in ClinVar as [Benign]. Clinvar id is 368590.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.193 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALAS2 | NM_000032.5 | c.*56A>C | 3_prime_UTR_variant | 11/11 | ENST00000650242.1 | NP_000023.2 | ||
ALAS2 | NM_001037967.4 | c.*56A>C | 3_prime_UTR_variant | 10/10 | NP_001033056.1 | |||
ALAS2 | NM_001037968.4 | c.*56A>C | 3_prime_UTR_variant | 11/11 | NP_001033057.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALAS2 | ENST00000650242.1 | c.*56A>C | 3_prime_UTR_variant | 11/11 | NM_000032.5 | ENSP00000497236 | P1 | |||
ALAS2 | ENST00000335854.8 | c.*56A>C | 3_prime_UTR_variant | 10/10 | 2 | ENSP00000337131 | ||||
ALAS2 | ENST00000396198.7 | c.*56A>C | 3_prime_UTR_variant | 11/11 | 5 | ENSP00000379501 | ||||
ALAS2 | ENST00000498636.1 | c.*118A>C | 3_prime_UTR_variant | 5/5 | 3 | ENSP00000495662 |
Frequencies
GnomAD3 genomes AF: 0.0567 AC: 6313AN: 111429Hom.: 456 Cov.: 22 AF XY: 0.0514 AC XY: 1730AN XY: 33683
GnomAD3 genomes
AF:
AC:
6313
AN:
111429
Hom.:
Cov.:
22
AF XY:
AC XY:
1730
AN XY:
33683
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00620 AC: 6582AN: 1061287Hom.: 441 Cov.: 27 AF XY: 0.00509 AC XY: 1717AN XY: 337303
GnomAD4 exome
AF:
AC:
6582
AN:
1061287
Hom.:
Cov.:
27
AF XY:
AC XY:
1717
AN XY:
337303
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0568 AC: 6329AN: 111484Hom.: 457 Cov.: 22 AF XY: 0.0515 AC XY: 1739AN XY: 33748
GnomAD4 genome
AF:
AC:
6329
AN:
111484
Hom.:
Cov.:
22
AF XY:
AC XY:
1739
AN XY:
33748
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 28, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
X-linked sideroblastic anemia 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at